Decreased muscle ACE activity enhances functional response to endurance training in rats, without change in muscle oxidative capacity or contractile phenotype

Journal of Applied Physiology

Volumn 107, Issue 1, 2009, Pages 346-353

  Habouzit, Estelle ^a   Richard, Hélène ^a   Sanchez, Hervé ^a   Koulmann, Nathalie ^a   Serrurier, Bernard ^a   Monnet, Rachel ^a   Ventura Clapier, Renée ^b,c   Bigard, Xavier ^a  

^a CENTRE DE RECHERCHES   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Universite Paris Sud   (France)

Author keywords

Angiotensin I converting enzyme inhibitor; Mitochondria; Myosin heavy chain; Perindopril; Running performance

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ENDURANCE; ENZYME ACTIVITY; FEMALE; MUSCLE CONTRACTILITY; MUSCLE TRAINING; NONHUMAN; OXIDATION KINETICS; PHENOTYPE; PRIORITY JOURNAL; RAT; REVIEW; TREADMILL EXERCISE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CITRATE (SI)-SYNTHASE; FEMALE; MITOCHONDRIA, MUSCLE; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SKELETAL; MUSCLE FIBERS, SLOW-TWITCH; MYOSIN HEAVY CHAINS; OXYGEN CONSUMPTION; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; PHENOTYPE; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL EXERTION; RATS; RATS, WISTAR;

EID: 67650076212     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.91443.2008     Document Type: Review

References (35)

1. Agbulut O, Li Z, Mouly V, Butler-Browne GS. Analysis of skeletal and cardiac muscle from desmin knockout and normal mice by high resolution separation of myosin heavy-chain isoforms. Biol Cell 88: 131-135, 1996.
2. Azizi M, Ezan E, Nicolet L, Grognet JM, Menard J. High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline. A new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 30: 1015-1019, 1997.
3. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX, Ventura-Clapier R. Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96: 59-64, 2004.
4. Bassett DR, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32: 70-84, 2000.
5. 2 max response to exercise training: results from the HERITAGE Family Study. J Appl Physiol 87: 1003-1008, 1999.
6. Boushel R, Langberg H, Gemmer C, Olesen J, Crameri R, Scheede C, Sander M, Kjær M. Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise. J Physiol 543: 691-698, 2002.
7. Dragovic T, Minhall R, Jackman HL, Wang LX, Erdos EG. Kininase II-type enzymes: their putative role in muscle energy metabolism. Diabetes 45, Suppl 1: S34-S37, 1996.
8. Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 99: 3043-3049, 1999.
9. Flück M, Hoppeler H. Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 146: 159-216, 2003.
10. Jondeau GCDJ, Dubourg O, Bourdarias JP. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation. Am J Cardiol 79: 635-638, 1997.
11. Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype? Exerc Sport Sci Rev 30: 184-190, 2002.
12. Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 35: 855-866, 2003.
13. Junot C, Nicolet L, Ezan E, Gonzales MF, Menard J, Azizi M. Effect of angiotensin-converting enzyme inhibition on plasma, urine and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats. J Pharmacol Exp Ther 291: 982-987, 1999.
14. Koulmann N, Bigard AX. Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise. Pflügers Arch 452: 125-139, 2006.
15. Kuznetsov AV, Veksler VI, Gellerich FN, Saks Margreiter R VA, Kunz WS. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 3: 965-976, 2008.
16. Momken I, Kahapip J, Bahi L, Badoual T, Hittinger L, Ventura-Clapier R, Veksler V. Does angiotensin-converting enzyme inhibition improve the energetic status of cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol 35: 399-407, 2003.
17. Morrell NW, Danilov SM, Satyan KB, Morris KG, Stenmark KR. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension. Cardiovasc Res 34: 393-403, 1997.
18. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2001 update. Med Sci Sports Exerc 34: 1219-1233, 2002.
19. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2003 update. Med Sci Sports Exerc 36: 1451-1469, 2004.
20. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990.
21. Roltsch MH, Brown MD, Hand BD, Kostek MC, Phares DA, Huberty A, Douglass LW, Ferrell RE, Hagberg JM. No association between ACE I/D polymorphism and cardiovascular hemodynamics during exercise in young women. Int J Sports Med 26: 638-644, 2005.
22. Rouyer O, Zoll J, Daussin F, Damge C, Helms P, Talha S, Rasseneur L, Piquard F, Geny B. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin- induced diabetic rats. Exp Physiol 92: 1047-1056, 2007.
23. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
24. Stroth U, Unger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 33, Suppl 1: S21-S28, 1999.
25. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993.
26. Titchenal CA. Exercise and food intake. What is the relationship? Sports Med 6: 135-145, 1988.
27. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T, Yano T, Shichiri M. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37: 300-307, 1994.
28. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892: 191-196, 1987.
29. Vescovo G, Dalla Libera L, Serafini F, Leprotti C, Facchin L, Volterrani M, Ceconi C, Ambrosio GB. Improved exercise tolerance after losartan and enalapril in heart failure. Correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 98: 1742-1749, 1998.
30. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE. The ACE gene and muscle performance. Nature 403: 614, 2000.
31. Woods DR, World M, Rayson MP, Williams AG, Jubb M, Jamshidi Y, Hayward M, Mary DA, Humphries SE, Montgomery HE. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol 86: 240-244, 2002.
32. Yamaguchi F, Kawana K, Tanonaka K, Kamano I, Igarashi T, Gen E, Fujimoto Y, Maki T, Sanbe A, Nasa Y, Takeo S. Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril. Br J Pharmacol 126: 1585-1593, 2001.
33. Zhang B, Shono N, Fan P, Ando S, Xu H, Jimi S, Miura S, Kumagai K, Win KM, Matsunaga A, Iwasaski H, Saku K. Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice. Hypertens Res 28: 681-688, 2005.
34. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 63: 139-144, 2003.
35. Zoll J, Monassier L, Garnier A, N'Guessan B, Mettauer B, Veksler V, Piquard F, Ventura-Clapier R, Geny B. ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101: 385-391, 2006.